Sputnik V vaccine shows 92 per cent efficacy in ongoing phase III trials in Russia
The confirmation is based on the first interim data from the double-blind, randomized, placebo-controlled Phase III clinical…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.